CMS Reimbursement Shift in Prostate Cancer: Streamlining Radiotracer Payments

David Albala, MD, discusses how starting October 1st, CMS will reimburse imaging centers directly, simplifying the process and removing reimbursement concerns for physicians ordering radiotracer tests.

Video Player is loading.

Play Video

Play

Mute

Current Time 0:00

/

Duration 0:00

Loaded: 0%

Stream Type LIVE

Seek to live, currently behind liveLIVE

Remaining Time -0:00

 

1x

Playback Rate

Chapters

• Chapters

Descriptions

• descriptions off, selected

Captions

• captions settings, opens captions settings dialog
• captions off, selected

Audio Track

Fullscreen

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

Text

ColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-Transparent

Background

ColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparent

Window

ColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque

Font Size

50%75%100%125%150%175%200%300%400%

Text Edge Style

NoneRaisedDepressedUniformDropshadow

Font Family

Proportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps

Reset restore all settings to the default valuesDone

Close Modal Dialog

End of dialog window.

Close Modal Dialog

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

EP: 1.An Overview of PSMA-PET Scans and Prostate Cancer Imaging

EP: 2.Advancements in Prostate Cancer Imaging: The Evolution of PET Scans

EP: 3.Prostate Cancer Imaging: PSMA Agents and Radiotracer Options

EP: 4.Challenges and Progress in Advanced Imaging for Prostate Cancer

Now Viewing

EP: 5.CMS Reimbursement Shift in Prostate Cancer: Streamlining Radiotracer Payments

EP: 6.Prostate Cancer Imaging and Care in 2023: Best Practices

EP: 7.Practical Guidance for Prostate Cancer Imaging: PSMA-PET Scans and Patient Selection

Related Videos

Potential Impact of PET/CT Imaging on Improving Patient Care

Overview of Clinical Trials for New Imaging Options for Kidney Cancer

Advances in Imaging for Kidney Cancer Diagnosis and Management

Staging and Treatment Decisions for Kidney Cancer

The Role of a Multidisciplinary Team in Managing Kidney Cancer

Limitations of Conventional Imaging for Assessing Renal Masses

Diagnostic Tests for Kidney Cancer

A Growing Incidence of Renal Masses

Future Directions in Prostate Cancer Treatment

Metastatic Prostate Cancer Treatment Approach

Related Content

Advertisement

July 19th 2021

UroView: The Role of Liquid Biomarkers for Early Detection of Prostate Cancer

David Albala, MD Judd W. Moul, MD

This article features insights from David Albala, MD, and Judd W. Moul, MD, on using liquid biomarker-based testing for the early detection of prostate cancer.

May 27th 2021

UroView: Gallium 68 PSMA–Targeted PET Imaging in Prostate Cancer: Staging and Outcomes

Phillip Kuo, MD, PhD Andre L. Abreu, MD

This article features insights from Phillip Kuo, MD, PhD, and Andre Abreu, MD, on gallium 68 PSMA-targeted PET imaging in prostate cancer.

May 17th 2021

UroView: The Importance of Image Quality in the Urological Workflow

This article features insights from a urology expert, Bradley Schwartz, DO, FACS, on the importance of image quality and radiation safety.

Related Content

UroViewUse of Targeted Imaging Modalities in Prostate Cancer: Key Challenges and Considerations

UroView

|

Use of Targeted Imaging Modalities in Prostate Cancer: Key Challenges and Considerations

Advertisement

July 19th 2021

UroView: The Role of Liquid Biomarkers for Early Detection of Prostate Cancer

David Albala, MD Judd W. Moul, MD

This article features insights from David Albala, MD, and Judd W. Moul, MD, on using liquid biomarker-based testing for the early detection of prostate cancer.

May 27th 2021

UroView: Gallium 68 PSMA–Targeted PET Imaging in Prostate Cancer: Staging and Outcomes

Phillip Kuo, MD, PhD Andre L. Abreu, MD

This article features insights from Phillip Kuo, MD, PhD, and Andre Abreu, MD, on gallium 68 PSMA-targeted PET imaging in prostate cancer.

May 17th 2021

UroView: The Importance of Image Quality in the Urological Workflow

This article features insights from a urology expert, Bradley Schwartz, DO, FACS, on the importance of image quality and radiation safety.